Lin Fanyu, Li Haoye, Zhu Keying, Wu YangXiaolong, Fan Qile, Ding Jinxi, Li Wei
School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, People's Republic of China.
Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing, People's Republic of China.
J Pharm Policy Pract. 2025 Sep 8;18(1):2547679. doi: 10.1080/20523211.2025.2547679. eCollection 2025.
As a key component of China's healthcare reform, the national centralized drug procurement (NCDP) policy has significantly influenced physician behavior regarding generic substitution. Therefore, it is essential to investigate the mechanisms underlying physicians' decisions to prescribe bid-winning generics under the NCDP, to provide empirical evidence for policy optimization, and to support the broader implementation of generic substitution strategies.
Drawing upon the theory of planned behavior (TPB), a conceptual model was developed, and a corresponding scale was constructed. Structural equation modelling (SEM) was employed to examine the influencing mechanisms, focusing on the relationships among subjective attitude, subjective norms, perceived behavioral control, subjective willingness, and actual prescribing behavior.
The findings indicated that subjective attitude was the primary driver of physicians' intentions to prescribe bid-winning generics. Subjective norms did not exert a statistically significant effect on prescribing willingness, while perceived behavioral control was found to have a negative influence on intention and minimal impact on actual substitution behavior. Subjective willingness has emerged as a critical mediating factor that directly shapes physicians' substitution behavior.
This study highlights the importance of enhancing physicians' positive attitudes towards bid-winning generics, fostering a supportive normative environment, and mitigating excessive perceived behavioral control. These strategies may strengthen prescribing intentions, support effective and sustainable implementation of the NCDP, promote generic substitution, and reduce patients' medication costs.
作为中国医疗改革的关键组成部分,国家集中带量采购(NCDP)政策对医生的仿制药替代行为产生了重大影响。因此,有必要探究医生在国家集中带量采购政策下选择开具中选仿制药的决策机制,为政策优化提供实证依据,并支持仿制药替代策略的更广泛实施。
基于计划行为理论(TPB)构建了一个概念模型,并编制了相应的量表。采用结构方程模型(SEM)来检验影响机制,重点关注主观态度、主观规范、感知行为控制、主观意愿和实际处方行为之间的关系。
研究结果表明,主观态度是医生开具中选仿制药意图的主要驱动因素。主观规范对处方意愿没有统计学上的显著影响,而感知行为控制对意图有负面影响,对实际替代行为的影响最小。主观意愿已成为直接影响医生替代行为的关键中介因素。
本研究强调了增强医生对中选仿制药的积极态度、营造支持性规范环境以及减轻过度的感知行为控制的重要性。这些策略可能会强化处方意图,支持国家集中带量采购政策的有效和可持续实施,促进仿制药替代,并降低患者的用药成本。